[Managing cutaneous toxicities of targeted therapies]

Yoshio Kiyohara1

  • 1Division of Dermatology, Shizuoka Cancer Center Hospital, Shizuoka 411-8777, Japan.

Insights

Molecularly targeted cancer therapies can cause skin side effects, impacting patient quality of life. Early intervention with skincare and multidisciplinary team collaboration is key to managing these reactions and ensuring treatment success.

Area of Science:

  • Oncology and Dermatology
  • Cancer Therapeutics
  • Cutaneous Medicine

Context:

  • Molecularly targeted therapies are increasingly used for cancer treatment.
  • These therapies frequently cause unique cutaneous side effects like hand-foot syndrome, rash, dry skin, and paronychia.
  • These side effects can significantly impair patients' quality of life and lead to treatment discontinuation.

Purpose:

  • To highlight the common cutaneous side effects associated with molecularly targeted cancer therapies.
  • To emphasize the importance of early diagnosis and management of these side effects.
  • To advocate for a multidisciplinary approach involving oncologists, dermatologists, and nurses for preventative skincare and treatment.

Summary:

  • Cutaneous side effects are a common challenge in molecularly targeted cancer therapy.
  • Management strategies include emollients, topical antibiotics, corticosteroids, and antihistamines.
  • Preventative skincare focusing on moisture retention, cleanliness, and protection is crucial.

Impact:

  • Effective management of skin toxicities can improve patient quality of life.
  • Proactive and collaborative care can prevent treatment termination, enhancing anticancer therapy success.
  • This approach balances therapeutic benefits with the management of cutaneous reactions.

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...